ArticleOncotarget2016

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Chinami Makii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.